TOWNHEAD SURGERY
TOWN HEAD, SETTLE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 23 | 23 | 100.0% | |
| HF 4 | 2011 | 19 | 19 | 100.0% | |
| HF 4 | 2012 | 21 | 21 | 100.0% | |
| HF 4 | 2013 | 18 | 22 | 81.8% | |
| HF004 | 2014 | 28 | 28 | 100.0% | |
| HF004 | 2015 | 26 | 30 | 86.7% | |
| HF004 | 2016 | 32 | 33 | 97.0% | |
| HF004 | 2017 | 35 | 36 | 97.2% | |
| HF004 | 2018 | 34 | 35 | 97.1% | |
| HF004 | 2019 | 37 | 37 | 100.0% | |
| HF004 | 2020 | 30 | 31 | 96.8% | |
| HF006 | 2021 | 39 | 39 | 100.0% | |
| HF006 | 2022 | 51 | 51 | 100.0% | |
| HF006 | 2023 | 54 | 54 | 100.0% |
